glp 1 and gut microbiome A Specific Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent Gut-Brain Axis Mechanism: Cell Metabolism The Interplay Between GLP-1-Based Therapies,

Melanotan 1 is a synthetic linear tridecapeptide a 13-amino-acid analog of the bodys own -melanocyte-stimulating hormone (-MSH)

Gastric mucosal damage in experimental diabetes in rats: Role of endogenous glutathione

This natural powder supplement increases satiety and helps control hunger by affecting the brains appetite centers

By combining multi-omics technologies such as metabolomics, single-cell transcriptomics and spatial omics, we systematically depict the dynamic changes of GSH in different tissues (such as liver, brain, tumor tissue, etc.) and under different disease states (such as normal, inflammatory, cancerous, etc.), and deeply analyze the functional mechanism of GSH in different physiological and pathological backgrounds, providing a more comprehensive theoretical basis for the diagnosis, treatment and prognosis of diseases